Literature DB >> 3221220

Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension.

J Seckl1, S Lightman.   

Abstract

The cerebrospinal fluid (CSF) concentrations of arginine vasopressin (AVP) and oxytocin (OT) were investigated both in patients with benign intracranial hypertension and in age and sex matched controls. Twenty eight lumbar punctures were performed on 15 patients with benign intracranial hypertension as part of their routine investigation and therapy. All patients had raised intracranial pressure (27.4, SE 1.7 cm.CSF). CSF AVP levels were significantly elevated in benign intracranial hypertension (2.1, SE 0.3 pmol/l) compared with controls (0.7, SE 0.1 pmol/l, p less than 0.001) but CSF OT concentrations were similar in both groups. CSF osmolality and plasma AVP and osmolality were identical in patients and controls. There was no correlation between CSF AVP concentration and intracranial pressure. The selective elevation of AVP in CSF may be of importance in the pathogenesis of raised intracranial pressure in benign intracranial hypertension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3221220      PMCID: PMC1032770          DOI: 10.1136/jnnp.51.12.1538

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  Haemodynamic effects of arginine-vasopressin microinjections into the nucleus tractus solitarius: a comparative study of vasopressin, a selective vasopressin receptor agonist and antagonist, and oxytocin.

Authors:  M Vallejo; D A Carter; S L Lightman
Journal:  Neurosci Lett       Date:  1984-12-21       Impact factor: 3.046

2.  Effects of halothane and fentanyl anesthesia on resistance to reabsorption of CSF.

Authors:  A A Artru
Journal:  J Neurosurg       Date:  1984-02       Impact factor: 5.115

3.  Cerebrospinal fluid vasopressin and increased intracranial pressure.

Authors:  P S Sørensen; F Gjerris; M Hammer
Journal:  Ann Neurol       Date:  1984-05       Impact factor: 10.422

4.  Central infusion of vasopressin decreased plasma vasopressin concentration in dogs.

Authors:  B C Wang; L Share; J T Crofton
Journal:  Am J Physiol       Date:  1982-11

5.  Brain water accumulation after the central administration of vasopressin.

Authors:  T Dóczi; P Szerdahelyi; K Gulya; J Kiss
Journal:  Neurosurgery       Date:  1982-09       Impact factor: 4.654

6.  Involvement of vasopressin in brain edema formation: further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage.

Authors:  T Dóczi; F A László; P Szerdahelyi; F Joó
Journal:  Neurosurgery       Date:  1984-04       Impact factor: 4.654

7.  Arginine vasopressin levels in cerebrospinal fluid in neurological disease.

Authors:  A C Reid; J J Morton
Journal:  J Neurol Sci       Date:  1982-05       Impact factor: 3.181

8.  Central effects of arginine vasopressin on blood pressure in rats.

Authors:  Q J Pittman; D Lawrence; L McLean
Journal:  Endocrinology       Date:  1982-03       Impact factor: 4.736

9.  Benign intracranial hypertension and disorders of CSF absorption.

Authors:  P Janny; J Chazal; G Colnet; B Irthum; A M Georget
Journal:  Surg Neurol       Date:  1981-03

10.  Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage.

Authors:  H M Mather; V Ang; J S Jenkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

View more
  6 in total

1.  Intracerebroventricular vasopressin reduces CSF absorption rate in the conscious goat.

Authors:  J R Seckl; S L Lightman
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children.

Authors:  D S Carson; S W Berquist; T H Trujillo; J P Garner; S L Hannah; S A Hyde; R D Sumiyoshi; L P Jackson; J K Moss; M C Strehlow; S H Cheshier; S Partap; A Y Hardan; K J Parker
Journal:  Mol Psychiatry       Date:  2014-11-04       Impact factor: 15.992

3.  Cerebrospinal fluid estrone in pseudotumor cerebri: a change in cerebral steroid hormone metabolism?

Authors:  V Toscano; G Sancesario; P Bianchi; C Cicardi; D Casilli; P Giacomini
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

Review 4.  An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics.

Authors:  Claire A Sheldon; Young Joon Kwon; Grant T Liu; Shana E McCormack
Journal:  Pediatr Res       Date:  2014-11-24       Impact factor: 3.756

5.  Plasma and cerebrospinal fluid arginine vasopressin in patients with and without fever.

Authors:  P M Sharples; J R Seckl; D Human; S L Lightman; D B Dunger
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

6.  Addison's disease presenting with idiopathic intracranial hypertension in 24-year-old woman: a case report.

Authors:  Dushyant Sharma; Rohini Mukherjee; Peter Moore; Daniel J Cuthbertson
Journal:  J Med Case Rep       Date:  2010-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.